Inventor

YAMASAKI MOTOO

JP77 patents

⚠️ This page may combine multiple inventors who share the name “YAMASAKI MOTOO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

YAMASAKI MOTOO

KYOWA HAKKO KOGYO KK

Antibody composition-producing cell

Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferase

Method of modulating the activity of functional immune molecules

Cells producing antibody compositions with increased antibody dependent cytotoxic activity

Process for purifying antibody

Recombinant antibody and antibody fragment

Polypeptide derivatives of human granulocyte colony stimulating factor

Platelet production promoting agent

G-CSF conjugate

Polypeptide derivatives of human granulocyte colony stimulating factor

DNA encoding human granulocyte colony stimulating factor plasmids and host cells comprising same, and methods of expressing the encoded polypeptide

Polypeptide derivatives of human granulocyte colony stimulating factor

Toxin conjugates

Oxyntomodulin peptide having cardiotonic activity and insulin release-bromating activity

Polypeptide derivatives of human granulocyte colony stimulating factor

Anti-fibroblast growth factor-8 monoclonal antibody

Anti-fibroblast growth factor-8 monoclonal antibody

Human 26S proteasome subunit components

hG-CSF fusion polypeptide having c-mpl activity, DNA coding for same and methods of treating anemia using same

Toxin conjugates

Vascular smooth muscle cell growth factor

Chemically modified polypeptides

Strains of streptomyces producing endothelin antagonistic peptides

Endothelin-antagonizing peptide

Monoclonal antibody against human telomerase catalytic subunit

Phospholipase C-inhibiting peptides

KYOWA HAKKO KIRIN CO LTD

Antibody composition-producing cell

Methods for producing antibody compositions with increased ADCC

Method of modulating the activity of functional immune molecules to CD52

Antibody composition-producing cell in which enzyme expression is inhibited by RNAi

Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor

Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation

Method of modulating the activity of functional immune molecules to interleukin-5 receptor protein

Method of modulating the activity of functional immune molecules

Method of modulating the activity of functional immune molecules to Her-2

Method of modulating the activity of functional immune molecules to CXCR4 protein

Method of modulating the activity of functional immune molecules

Method of modulating the activity of functional immune molecules to GM2

Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation

Method for treating Th2-mediated disease

Method of modulating the activity of functional immune molecules

Antibody composition-producing cell

KANDA YUTAKA

Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase

Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation

Antibody composition-producing cell

Glycoengineered, recombinant antibody

Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody

HANAI NOBUO

Method of modulating the activity of functional immune molecules

SHITARA KENYA

Method for producing recombinant antibody and antibody fragment thereof

YAMASAKI MOTOO

Antibody and antibody fragment introduced new modification sites